New toolkit aims to boost PrEP access for youth in alabama and botswana

NCT ID NCT07597824

Not yet recruiting Prevention Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at how to make HIV prevention pills (PrEP) easier for young people to get and keep using. Researchers will follow 1000 current or eligible PrEP users in Alabama and Botswana for 2 years. They will also create and test a decision-support toolkit to help patients and doctors talk about PrEP. The goal is to improve access and reduce HIV infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could make it easier for young people to get and stay on PrEP, reducing HIV infections in these communities.
What could go wrong: This is an observational study, not a treatment trial. The toolkit may not work as hoped, and results may not apply to other regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTRACEPTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

posterior leukoencephalopathy syndrome HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONTRACEPTION HIV INFECTIONS PREP

Contacts and locations

Locations

Princess Marina Hospital

Bontleng, Gaborone, Botswana

More trials for these conditions

Other studies related to the condition(s) this trial covers.